US › Healthcare

biote Corp (BTMD)

US · Healthcare · Medical Care Facilities

$2.27-0.87%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$44.9M
Revenue YoY
-8.3%
Net profit
$2.3M
Profit YoY
-83.4%
EPS
$0.08
EPS estimate
$0.08
Net margin
5.1%

EPS came in at 0.08 against a street estimate of 0.08 — a beat of 0.0%.

Key statistics

Market cap
$80.0M
P/E
5.2
Forward P/E
6.2
P/B
2.96
Book value
$-1.87
EPS (TTM)
$0.43
52-week high
$4.20
52-week low
$1.27
50-day MA
$2.19
200-day MA
$2.25
Beta
1.65

Analyst view

Analysts rate biote Corp a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $2.73.

Shareholding

Insiders
10.39%
Institutions
66.52%

Largest institutional holders

FundStake
325 Capital LLC14.99%
Bandera Partners LLC6.81%
BlackRock Inc5.73%
Vanguard Capital Management, LLC3.67%
Acadian Asset Management LLC2.30%
State Street Corp2.13%
Geode Capital Management, LLC2.03%
Dimensional Fund Advisors, Inc.1.79%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for biote Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.